- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04606251
Home-Based Telerehabilitation for People With Alzheimer Disease
Home-Based Telerehabilitation for People With Alzheimer Disease: A Randomized Controlled Study
Study Overview
Detailed Description
Exercise application in the study will take 6 weeks. Evaluations will be made twice, at the beginning and end of the exercise application.
Functional mobility was measured with the 5-Times Sit-and-Stand Test (5XSTS) and Timed Up and Go Test (TUG); static balance with One-Leg Stand Test; functional independence level with Functional Independence Scale (FIM); daily living activities will be evaluated with the Katz Activities of Daily Living Scale.
The general cognitive level of the cases was determined by Mini-Mental State Examination; Depressive symptoms will be measured with the Geriatric Depression Scale-Short Form, and anxiety levels will be measured with the Beck Anxiety Scale.
The care burden of caregivers will be assessed with the Zarit Care Burden Scale, and caregiver's well-being will be assessed with the Warwick-Edinburgh Mental Well-being Scale.
Primary outcome measures are Mini Mental Test, Timed Up&Go Test, and the 5-Times Sit-and-Stand Test .
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Istanbul, Turkey
- Istanbul University-Cerrahpasa
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Over 65 years old,
- Diagnosed with Alzheimer's disease according to the National Institute of Neurological and Communicative Disorders and Stroke and the Alzheimer's Disease (NINCDS-ADRDA) criteria,
- Scoring between 0-2 points according to the Clinical Dementia Rating Scale (with mild-moderate dementia-related symptoms),
- Have used any dementia medication such as cholinesterase inhibitors and memantine for at least the last month,
- Mini Mental Test score between 13-24 points,
- The caregiver living with is sufficient in the use of technology,
- Cases who could understand the instructions given in Turkish were included in the study.
Exclusion Criteria:
- Dementia with Lewy bodies, frontotemporal dementia and one of the other types of dementia,
- Having a pulmonary, neurological, musculoskeletal or rheumatological disease that may prevent exercise,
- Unstable medical condition (uncontrolled diabetes or hypertension, deep vein thrombosis, etc.),
- Modified Charlson Comorbidity Index score greater than 6,
- Receiving any rehabilitation service from an institution or person,
- Having regular exercise habits,
- Subjects with visual or auditory deficits or behavioral problems that would make communication difficult were not included in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
EXPERIMENTAL: Arm 1: Exercise Group
This group will consist of the subjects taken for 6 weeks of exercise.
|
The intervention to be carried out in the study consists of physical exercises for the neck, upper and lower extremities, and trunk; It is a program that includes the addition of cognitive tasks such as memory, word finding, processing during each repetition.
|
|
NO_INTERVENTION: Arm 2: Control Group
This group will consist of the subjects who did not receive any intervention for 6 weeks and were evaluated before and after 6 weeks.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cognitive Function-Mini Mental Test
Time Frame: 6 weeks
|
Mini Mental Test evaluates the cognitive skills.
For each question of the test, the correct answer is scored as 1 point, the incorrect answer 0 point.
Test is divided into two sections, the first of which requires vocal responses only and covers orientation, memory, and attention; the maximum score is 21.
The second part tests ability to name, follow verbal and written commands, write a sentence spontaneously, and copy a complex polygon; the maximum score is 9.
|
6 weeks
|
|
Timed Up and Go Test
Time Frame: 6 weeks
|
Timed Up and Go Test measure the level of functional mobility skills and, assess fall risk and balance.
The time elapsed between standing up from the sitting position, walking the distance of 3 meters, coming back and sitting back on the chair is recorded.
The shorter time reflect the better performance.
|
6 weeks
|
|
Physical Mobility-5 Time Sit to Stand Test
Time Frame: 6 weeks
|
5 Time Sit to Stand Test measure the level of functional mobility skills and, assess fall risk and lower extremity strength.
The test measures the time taken to stand five times from a sitting position as quickly as possible.
The shorter time reflect the better performance.
|
6 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Balance-One Leg Stance Test
Time Frame: 6 weeks
|
One Leg Stance Test evaluates the static balance.
The time of standing unsupported on one leg with eyes open, hands beside the body is recorded.
The test is finished when the patient's foot touches the ground.
Longer duration indicates good balance.
|
6 weeks
|
|
Activities of Daily Living-Katz Activities of Daily Living Scale
Time Frame: 6 weeks
|
Katz Activities of Daily Living Scale is a questionnaire that measures the ability of people to perform daily activities functionally.
The Index ranks adequacy of performance in the six functions of bathing, dressing, toileting, transferring, continence, and feeding.
A score of 6 indicates full function, 4 indicates moderate impairment, and 2 or less indicates severe functional impairment.
|
6 weeks
|
|
Depression-Geriatric Depression Scale
Time Frame: 6 weeks
|
The Geriatric Depression Scale is a 30-item self-report measure designed to assess and screen depressive symptoms among older adults.
Each item on the GDS is scored with one point for a depressive response.
Items are summed to determine the total score with a maximum of 30 points.
General interpretive guidelines are as follows: scores ranging from 0 to 9 indicate normal mood, scores of 10 to 19 indicate mild depressive symptoms, and scores of 20 to 30 indicate severe depressive symptoms.
|
6 weeks
|
|
Anxiety-Beck Anxiety Inventory
Time Frame: 6 weeks
|
The beck anxiety scale is a questionnaire used to measure the anxiety levels of individuals.
Respondents are asked to report the extent to which they have been bothered by each of the 21 symptoms in the week preceding their completion of the Beck Anxiety Inventory.
Each symptom item has four possible answer choices: Not at All (0 point); Mildly (1 point), Moderately (2 point), and; Severely (3 point).
A total score of 0-7 is interpreted as a "Minimal" level of anxiety; 8-15 as "Mild"; 16-25 as "Moderate", and; 26-63 as "Severe".
|
6 weeks
|
|
Burden-Zarit Burden Scale
Time Frame: 6 weeks
|
The Zarit Burden Scale is a questionnaire that measures the care burden of caregivers.
It contains 22 items.
Each item on the interview is a statement which the caregiver is asked to endorse using a 5-point scale.
Response options range from 0 (Never) to 4 (Nearly Always).
Higher scores indicate greater burden.
|
6 weeks
|
|
Well-being-Warwick Edinburgh Mental Well-being Scale
Time Frame: 6 weeks
|
Warwick-Edinburgh Mental Well-being Scale measures parameters such as coping with stress, being productive and beneficial.
The scale is scored by summing responses to each item answered on a 1 to 5 Likert scale.
The total score is obtained by summing the score for each of the 14 items.
The minimum scale score is 14 and the maximum is 70.
Higher scores are associated with higher levels of mental well-being.
|
6 weeks
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- Kübra Nur Menengiç, IUC
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Alzheimer Disease
-
ProgenaBiomeWithdrawnAlzheimer Disease | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3 | Alzheimer Disease 4 | Alzheimer Disease 7 | Alzheimer Disease 17 | Alzheimer Disease 5 | Alzheimer Disease 6 | Alzheimer Disease 8 | Alzheimer Disease 10 | Alzheimer... and other conditionsUnited States
-
Cognito Therapeutics, Inc.Active, not recruitingCognitive Impairment | Dementia | Alzheimer Disease | Mild Cognitive Impairment | Cognitive Decline | Alzheimer Disease, Early Onset | Alzheimer Disease, Late Onset | MCI | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Cognitive Impairment, Mild | Alzheimer Disease 1 | Dementia, Mild | Alzheimer... and other conditionsUnited States
-
Stanford UniversityNot yet recruitingMCI With Increased Risk for Alzheimer Disease | Alzheimer s DiseaseUnited States
-
University of California, Los AngelesRecruitingAlzheimer Disease | Dementia Alzheimer Type | Alzheimer&Amp;#39;s Disease (AD) | Alzheimer&Amp;Amp;#39;s Disease | Mild Alzheimer&Amp;Amp;#39;s Disease | Moderate Alzheimer&Amp;Amp;#39;s Disease | Alzheimer&Amp;#39;s DementiaUnited States
-
AphiosNot yet recruitingDementia | Alzheimer Disease 1 | Alzheimer Disease 2 | Alzheimer Disease 3
-
Heinrich-Heine University, DuesseldorfNot yet recruitingEarly Onset Alzheimer Disease | Alzheimer Disease (AD)Germany
-
Johns Hopkins UniversityNational Institutes of Health (NIH)Not yet recruiting
-
Xuanwu Hospital, BeijingEnrolling by invitation
-
Beijing Tiantan HospitalNot yet recruiting
-
Danyang Huichuang Medical Equipment Co., Ltd.RecruitingAlzheimer s DiseaseChina
Clinical Trials on Exercise
-
National Institute of Neurological Disorders and...TerminatedTraumatic Brain InjuryUnited States
-
University of Texas, El PasoRecruitingKnee Osteoarthritis | Knee Pain Chronic | Central Pain SyndromeUnited States
-
Aksaray University Training and Research HospitalCompletedExercise Training | Lactate Blood Increase | Cognitive Functions | BDNFTurkey (Türkiye)
-
University of Alabama at BirminghamCompletedCystic FibrosisUnited States
-
University of LisbonFundação para a Ciência e a TecnologiaActive, not recruiting
-
University of Missouri-ColumbiaCompleted
-
University of AlcalaCompletedMyofascial Pain | Myofascial Pain Syndrome | Post Needling Soreness | Myofascial Trigger Point PainSpain
-
Toronto Rehabilitation InstituteCompletedAcute Myeloid LeukemiaCanada
-
Bayero University Kano, NigeriaCompletedChronic Low Back PainNigeria
-
University College CorkRecruitingDepressive Disorder, MajorIreland